New Treatment Breakthrough for Long COVID Approved by FDA: HealthBioAI's groundbreaking trial with maraviroc and atorvastatin offers hope for millions worldwide.
New drug CaniVita shows promise in extending dogs' lives by up to 25% with pending FDA approval. Learn more about its potential benefits and ethical concerns.
FDA approves ZORYVE foam for Seborrheic Dermatitis. Arcutis Biotherapeutics introduces an effective steroid-free treatment for improved quality of life and disease management.
Medtronic's breakthrough PulseSelect Pulsed Field Ablation System for atrial fibrillation treatment receives FDA approval, offering a safer alternative with impressive success rates. Coming early 2024.
FDA approves Talvey, Johnson & Johnson's new treatment for advanced multiple myeloma patients. Offering hope and innovative action against the disease.